Menu Search
Equities

Grifols SA

GRF.P:MCE

Grifols SA

Actions
  • Price (EUR)9.21
  • Today's Change0.42 / 4.78%
  • Shares traded629.01k
  • 1 Year change+7.22%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024 16:37 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. The Company organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Its diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Its bio Supplies provides, mostly, biological products for non-therapeutic use.

  • Revenue in EUR (TTM)6.81bn
  • Net income in EUR151.80m
  • Incorporated1987
  • Employees23.74k
  • Location
    Grifols SAParque Empresarial Can Sant JoanAvinguda de la Generalitat, 152-158SANT CUGAT DEL VALLES 08174SpainESP
  • Phone+34 935710000
  • Fax+34 935710267
  • Websitehttps://www.grifols.com/
More ▼

Institutional shareholders

15.77%Per cent of shares held by top holders
HolderShares% Held
Brandes Investment Partners LPas of 31 Jan 202413.48m5.16%
The Vanguard Group, Inc.as of 30 Sep 20248.78m3.36%
Capital International Ltd.as of 30 Sep 20247.07m2.70%
Cobas Asset Management SGIIC SAas of 30 Sep 20242.79m1.07%
FIL Investments Internationalas of 31 Jul 20242.00m0.76%
AzValor Asset Management SGIIC SAas of 30 Jun 20241.79m0.68%
Robeco Institutional Asset Management BVas of 30 Sep 20241.66m0.63%
Santander Asset Management SA SGIICas of 30 Jun 20241.30m0.50%
HSBC Global Asset Management (France) SAas of 30 Sep 20241.24m0.48%
Sabadell Asset Management SA SGIIC SUas of 30 Jun 20241.13m0.43%
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.